Page 1 of Clinical Trials for Drug antineoplaston AS2-1, 59 Total Matches
- 1Not yet recruitingLast Updated: December 13, 2010Condition(s): Optic Nerve Glioma
- 2WithdrawnLast Updated: December 4, 2006Condition(s): Adenocarcinoma of the Prostate; Stage III Prostate Cancer; Stage IV Prostate Cancer; Recurrent Prostate Cancer
- 3Active, not recruitingLast Updated: July 23, 2008Condition(s): Brain and Central Nervous System Tumors
- 4TerminatedLast Updated: August 31, 2009Condition(s): Malignant Mesothelioma
- 5Active, not recruitingLast Updated: July 23, 2008Condition(s): Neuroblastoma
- 6Active, not recruitingLast Updated: July 23, 2008Condition(s): Brain and Central Nervous System Tumors
- 7Active, not recruitingLast Updated: July 23, 2008Condition(s): Brain and Central Nervous System Tumors
- 8RecruitingLast Updated: June 9, 2009Condition(s): Brain and Central Nervous System Tumors
- 9RecruitingLast Updated: June 9, 2009Condition(s): Brain and Central Nervous System Tumors
- 10Active, not recruitingLast Updated: January 21, 2009Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
- 11CompletedLast Updated: May 23, 2009Condition(s): Melanoma (Skin)
- 12Active, not recruitingLast Updated: July 14, 2009Condition(s): Brain and Central Nervous System Tumors
- 13RecruitingLast Updated: June 9, 2009Condition(s): Brain and Central Nervous System Tumors
- 14Active, not recruitingLast Updated: July 23, 2008Condition(s): Brain and Central Nervous System Tumors
- 15RecruitingLast Updated: June 9, 2009Condition(s): Brain and Central Nervous System Tumors
- 16Active, not recruitingLast Updated: July 23, 2008Condition(s): Sarcoma
- 17Active, not recruitingLast Updated: May 23, 2008Condition(s): Brain and Central Nervous System Tumors
- 18Active, not recruitingLast Updated: July 14, 2009Condition(s): Brain and Central Nervous System Tumors
- 19RecruitingLast Updated: June 9, 2009Condition(s): Brain and Central Nervous System Tumors
- 20RecruitingLast Updated: June 9, 2009Condition(s): Brain and Central Nervous System Tumors
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+antineoplaston+AS2-1
